D.Western Therapeutics Institute Inc (4576)

Currency in JPY
113.0
0.0(0.00%)
Closed·
4576 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 7 days
4576 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
112.0115.0
52 wk Range
64.0254.0
Key Statistics
Bid/Ask
113.00 / 115.00
Prev. Close
113
Open
112
Day's Range
112-115
52 wk Range
64-254
Volume
291.9K
Average Volume (3m)
757.75K
1-Year Change
67.65%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4576 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

D.Western Therapeutics Institute Inc Company Profile

D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on discovery and development of various drugs. The company offers GLANATEC and GLA-ALPHA, an ophthalmic solution for the treatment of glaucoma/ocular hypertension; DW-1001, an ophthalmic drug; DWR-2206, a regenerative medicine cell-product for bullous keratopathy; and DW-1002, an ophthalmic surgical adjuvant for cataract surgeries, and ILM, ALC, ERM, and PVR membrane staining. It is also developing DW-5LBT, a lidocaine patch for neuropathic pain after shingles; K-321 to treat fuch endothelial corneal dystrophy which is in Phase III clinical trials; and H-1337, a multi-kinase inhibitor that has started Phase IIb clinical trials for the treatment of glaucoma/ocular hypertension. The company was founded in 1999 and is headquartered in Nagoya, Japan.

Compare 4576 to Peers and Sector

Metrics to compare
4576
Peers
Sector
Relationship
P/E Ratio
−4.6x−5.7x−0.5x
PEG Ratio
−0.50−0.100.00
Price/Book
5.2x4.5x2.6x
Price / LTM Sales
11.1x33.9x3.3x
Upside (Analyst Target)
-58.4%43.5%
Fair Value Upside
Unlock10.0%6.9%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-3.41 / --
Revenue / Forecast
96.00M / --
EPS Revisions
Last 90 days

4576 Income Statement

People Also Watch

552.0
5202
+2.41%
5,421.0
4091
-0.70%
2,437.0
5482
+2.01%
3,308.0
6141
0.00%
457.5
8572
+1.33%

FAQ

What Stock Exchange Does D.Western Therapeutics Institute Trade On?

D.Western Therapeutics Institute is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for D.Western Therapeutics Institute?

The stock symbol for D.Western Therapeutics Institute is "4576."

What Is the D.Western Therapeutics Institute Market Cap?

As of today, D.Western Therapeutics Institute market cap is 5.21B.

What Is D.Western Therapeutics Institute's Earnings Per Share (TTM)?

The D.Western Therapeutics Institute EPS (TTM) is -29.40.

When Is the Next D.Western Therapeutics Institute Earnings Date?

D.Western Therapeutics Institute will release its next earnings report on 13 Aug 2025.

From a Technical Analysis Perspective, Is 4576 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has D.Western Therapeutics Institute Stock Split?

D.Western Therapeutics Institute has split 0 times.

How Many Employees Does D.Western Therapeutics Institute Have?

D.Western Therapeutics Institute has 21 employees.

What is the current trading status of D.Western Therapeutics Institute (4576)?

As of 07 Aug 2025, D.Western Therapeutics Institute (4576) is trading at a price of 113.00, with a previous close of 113.00. The stock has fluctuated within a day range of 112.00 to 115.00, while its 52-week range spans from 64.00 to 254.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.